LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70 | -97.8% | 206 | -97.1% | 0.00% | – |
| Q4 2022 | $3,235 | -94.2% | 7,188 | -88.8% | 0.00% | – |
| Q3 2022 | $56,000 | -80.0% | 63,937 | -73.7% | 0.00% | – |
| Q2 2022 | $280,000 | -80.8% | 243,483 | -70.9% | 0.00% | – |
| Q1 2022 | $1,462,000 | -46.1% | 835,925 | -0.1% | 0.00% | – |
| Q4 2021 | $2,713,000 | -7.7% | 837,078 | +14.2% | 0.00% | – |
| Q3 2021 | $2,940,000 | +293900.0% | 733,011 | +162791.3% | 0.00% | – |
| Q2 2021 | $1,000 | – | 450 | +476.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 78 | -97.4% | 0.00% | – |
| Q2 2020 | $6,000 | – | 3,000 | +1718.2% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 165 | -83.5% | 0.00% | – |
| Q2 2019 | $2,000 | – | 1,000 | +16566.7% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 6 | -97.8% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 273 | -43.7% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 485 | +18.9% | 0.00% | – |
| Q1 2017 | $4,000 | – | 408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
| Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
| ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
| Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
| HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
| Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
| Golden Green, Inc. | 14,824 | $24,000 | 0.02% |